We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the reasons behind the slight prevalence of breast cancer in the left breast, common tumor locations, and the importance of early detection and screening.

It's a question that might cross many minds, especially during breast self-examinations or after receiving a diagnosis: Is breast cancer more common in the left breast than the right? Recent research suggests a slight prevalence of breast cancer in the left breast. A comprehensive study in 2022, analyzing data from over 881,000 individuals diagnosed with breast cancer, observed that 50.8% of cases occurred in the left breast, while 49.2% were in the right. While this difference is statistically significant, the exact reasons behind it are still a subject of ongoing investigation by medical professionals and researchers.
Several theories attempt to explain why breast cancer might be more frequently diagnosed in the left breast. One prominent hypothesis relates to handedness. In Western countries, a vast majority of the population (around 85-90%) are right-handed. Researchers propose that right-handed individuals might be more adept at performing self-examinations on their left breast using their dominant hand, potentially leading to earlier detection of lumps or abnormalities. This improved ability to detect changes could, in turn, contribute to a higher number of left-sided breast cancer diagnoses.
Another factor considered is breast asymmetry. It's common for breasts to not be perfectly symmetrical; often, one breast is slightly larger than the other. While some studies have explored whether breast size or the amount of glandular tissue influences cancer risk, current evidence largely disproves a direct link between breast size and the risk of developing breast cancer. A 2019 study, for instance, found little to no association between breast size and breast cancer risk.
Regardless of the side, understanding where breast tumors are most commonly found is crucial for awareness and early detection. A review of over 2.4 million breast cancer diagnoses in the United States between 2004 and 2015 revealed that the most frequent location for a tumor was the upper outer quadrant of the breast. This area is located towards the armpit and is a significant portion of the breast tissue.
Beyond the prevalence, questions arise about whether breast cancer in the left breast behaves differently from cancer in the right breast. Some research has indicated potential differences in treatment response. A 2022 study comparing outcomes for left-sided and right-sided breast tumors found that left-sided tumors appeared to be slightly more resistant to chemotherapy. However, this finding is not universal, and other studies have yielded different results. For example, a smaller study conducted in Bahrain in 2020, examining a specific ethnic population, suggested that right-sided breast cancers in their cohort were more aggressive, with a reduced 5-year survival rate relative to tumor stage and size.
These differing findings highlight the complexity of breast cancer and the need for more extensive research to understand if there are consistent differences in how left-sided and right-sided breast cancers behave and respond to treatment across diverse populations.
The most critical factor in improving outcomes for breast cancer, regardless of the side affected, is early detection. Fortunately, increased awareness and improved screening methods mean that a significant majority of breast cancer diagnoses—about two-thirds (66%)—are made at an early stage, before the cancer has spread beyond the breast. This emphasizes the vital role of regular screening mammograms.
Medical experts strongly recommend adhering to established screening guidelines. For instance, the American Cancer Society suggests that women aged 45 to 54 with an average risk of breast cancer should undergo a screening mammogram annually. Women between the ages of 40 and 44 also have the option to begin annual screening if they choose.
It is essential to be aware of your breasts and report any changes to your doctor promptly. While the slight prevalence of left breast cancer is an area of research, any new lump, skin changes, nipple discharge, or other unusual symptoms should be evaluated by a healthcare professional. Early consultation can lead to timely diagnosis and effective treatment, significantly improving prognosis.
This information is for general awareness and educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026